Basic Study
Copyright ©The Author(s) 2024.
World J Diabetes. Mar 15, 2024; 15(3): 502-518
Published online Mar 15, 2024. doi: 10.4239/wjd.v15.i3.502
Figure 5
Figure 5 Jianpi Gushen Huayu Decoction moderated the toll-like receptor 4/nuclear factor-kappa B/NOD-like receptor family pyrin domain containing 3 pathway and ameliorated inflammatory injuries to kidneys. A: Western blotting results; B: Toll-like receptor 4 levels; C: p-P65/P65 levels; D: NOD-like receptor family pyrin domain containing 3 (NLRP3) levels; E: Apoptosis-associated speck-like protein containing a CARD (ASC) levels; F: Cleaved caspase-1/caspase-1 levels; G: Mature interleukin (IL)-1β/IL-1β levels; H: IL-18 levels; I: Nlrp3 levels; J: Asc levels; K: Casp1 levels; L: Il1b levels; M: Il18 levels. aP < 0.05 as compared to the control group; bP < 0.01 as compared to the control group; cP < 0.05 as compared to the model group; dP < 0.01 as compared to the model group. JPGSH: High-dose Jianpi Gushen Huayu Decoction; TLR4: toll-like receptor 4; NLRP3: NOD-like receptor family pyrin domain containing 3; ASC: Protein apoptosis-associated speck-like protein containing a CARD; IL: Interleukin.